The vaccine that goes in a dog’s nose is the intranasal kennel cough vaccine, which protects against the respiratory infections that cause canine infectious tracheobronchitis, commonly called kennel cough. The most widely used version is a combination product containing three live but weakened pathogens: Bordetella bronchiseptica (a bacterium), parainfluenza virus, and adenovirus type 2. Some formulations contain only Bordetella, while the trivalent versions cover all three at once.
What the Nasal Vaccine Protects Against
Kennel cough isn’t caused by a single germ. It’s a syndrome triggered by several respiratory pathogens, and the intranasal vaccine targets the most common culprits. Bordetella bronchiseptica is the bacterium most closely associated with the harsh, honking cough that gives the disease its name. Parainfluenza virus and adenovirus type 2 are viral contributors that can cause illness on their own or weaken a dog’s respiratory defenses enough for Bordetella to take hold.
The trivalent intranasal vaccine (covering all three) is widely available. One common brand is Nobivac Intra-Trac 3, made by Merck Animal Health. Your vet may carry a different brand, but the core ingredients are the same: modified live versions of these three pathogens, mixed into a liquid and delivered as drops into one or both nostrils.
Why It Goes in the Nose Instead of Under the Skin
Kennel cough infects the lining of the nose, throat, and airways. By delivering the vaccine directly to those surfaces, the intranasal route stimulates the immune system right where infection would actually start. The nasal lining produces a specific type of antibody called secretory IgA, which sits on the surface of respiratory tissue and intercepts pathogens before they can establish an infection. Injectable vaccines are good at generating antibodies in the bloodstream, but they don’t trigger this local respiratory defense as effectively.
Research comparing the two routes found that dogs vaccinated intranasally had significantly higher levels of Bordetella-reactive IgA in their blood compared to dogs that received the injectable version. The practical takeaway: the nasal vaccine primes both local and systemic immunity, while the injectable version primarily boosts systemic protection. This is why veterinary guidelines from the World Small Animal Veterinary Association note that the intranasal route is preferred for parainfluenza specifically, since the primary site of infection is the upper respiratory tract.
How Fast Protection Kicks In
One of the biggest advantages of the nasal vaccine is speed. Studies have demonstrated that intranasal Bordetella vaccines can provide protection against experimental challenge within 72 hours, and both intranasal and oral kennel cough vaccines proved effective at preventing disease just seven days after a single dose. Injectable Bordetella vaccines, by contrast, require two doses separated by a few weeks before full immunity develops.
This fast onset is why boarding facilities, groomers, and doggy daycares often require the vaccine at least a few days before your dog’s visit. If you’re planning ahead, getting the nasal vaccine a week or more before exposure gives the strongest window of protection.
What Happens During Administration
The vet or technician reconstitutes the freeze-dried vaccine components with a sterile liquid, draws the solution into a syringe (without a needle), and gently deposits it into one or both of your dog’s nostrils. The total volume is typically around 1 mL, though some products designed for small dogs use a 0.5 mL dose. The whole process takes just a few seconds. No injection, no needle.
Dogs commonly sneeze immediately after getting the drops, which can expel some of the vaccine. This is normal and expected. Even with a sneeze or two, enough vaccine contacts the nasal lining to generate an immune response. One important safety note: intranasal vaccines must never be injected under the skin or into muscle. These are live organisms formulated specifically for mucosal delivery, and injecting them can cause severe adverse reactions, including potentially fatal ones.
Common Side Effects
Most dogs tolerate the nasal vaccine well. The most frequent side effects are mild and mimic a slight cold: sneezing, a runny nose, and occasionally a light cough. These symptoms typically resolve within a day or two. They’re caused by the live (but weakened) organisms doing exactly what they’re supposed to do, stimulating an immune response in the respiratory tract.
If sneezing, coughing, or nasal discharge persists beyond two days or seems to worsen, that warrants a call to your vet. Serious reactions are rare, but dogs that are immunocompromised, currently sick, or pregnant may not be good candidates for the nasal vaccine. Dogs with a history of vaccine reactions should also be evaluated individually before receiving it.
When Puppies Can Get It
Puppies can receive the intranasal kennel cough vaccine earlier than many other vaccines. Some trivalent intranasal products are labeled for use in puppies as young as three weeks of age, though many brands specify a minimum age of eight weeks. The early eligibility matters for puppies in shelters or breeding facilities where respiratory infections spread quickly. For most pet owners, the vaccine is first given at or around the initial puppy visit, typically between six and eight weeks.
Research suggests that starting with an intranasal dose in puppies, then following up with an injectable booster later in the series, may be the most effective strategy. This combination primes both mucosal and systemic antibody responses, giving broader protection than either route alone.
How It Compares to the Oral Vaccine
There is also an oral Bordetella vaccine, which is squirted into the cheek pouch rather than the nose. In a head-to-head study, both the oral and intranasal versions effectively prevented disease seven days after vaccination when dogs were challenged with virulent Bordetella. The oral option can be easier to administer for dogs that resist having drops placed in their nose, and it avoids the post-vaccination sneezing. However, the oral vaccine typically covers only Bordetella, while the intranasal trivalent version adds protection against parainfluenza and adenovirus 2 in a single dose.
Your vet may recommend one form over the other based on your dog’s temperament, age, and exposure risk. Dogs that regularly visit boarding kennels, dog parks, grooming salons, or training classes face the highest risk and benefit most from the broader coverage of the trivalent nasal vaccine.